mergers and acquisitions

BioMarin Pharmaceutical Details Strategy Refresh, Voxzogo Competition and 40% Margin Goal at TD Cowen Confab

by
BioMarin Pharmaceutical corporate headquarters building with company logo and modern biotech facility exterior

“BioMarin Pharmaceutical’s leadership outlined a refreshed corporate strategy at the recent TD Cowen Healthcare Conference, focusing on business development, integration of recent acquisitions, and robust operational efficiencies. The company reaffirmed its target of approximately 40% non-GAAP operating margin in 2026 (excluding Amicus impact), while addressing emerging competition for its key growth driver Voxzogo and emphasizing … Read more

Lake Street Boosts Crexendo Price Target to $9 on Strategic Acquisition and Scale Benefits

by
Stock chart and analyst price target upgrade for Crexendo Inc. (CXDO) with Lake Street Capital logo

“Lake Street Capital has increased its price target on Crexendo (CXDO) from $8.50 to $9 while maintaining a Buy rating, citing the company’s recent $35 million acquisition of ESI as a value-accretive move that enhances scale, drives retail seat expansion, improves operating leverage, and supports stronger long-term margins in the cloud communications sector.” Lake Street … Read more

3 Things Investors Need to Know About the Healthcare Sector in 2026

by
Illustration of financial graphs overlaid with medical icons representing key healthcare investment trends in 2026

“The healthcare sector in 2026 is poised for transformation through rapid AI integration boosting efficiency and innovation, a surge in mergers and acquisitions driving consolidation and growth, and navigating regulatory shifts alongside economic pressures that create both challenges and undervalued opportunities for savvy investors.” Accelerating Adoption of AI and Digital Transformation The integration of artificial … Read more